InnoCare Pharma Ltd
SSE:688428

Watchlist Manager
InnoCare Pharma Ltd Logo
InnoCare Pharma Ltd
SSE:688428
Watchlist
Price: 13.3 CNY -7.06% Market Closed
Market Cap: 11.2B CNY
Have any thoughts about
InnoCare Pharma Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
InnoCare Pharma Ltd

Wall Street analysts forecast InnoCare Pharma Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for InnoCare Pharma Ltd is 16.22 CNY with a low forecast of 16.06 CNY and a high forecast of 16.7 CNY.

Lowest
Price Target
16.06 CNY
21% Upside
Average
Price Target
16.22 CNY
22% Upside
Highest
Price Target
16.7 CNY
26% Upside
InnoCare Pharma Ltd Competitors:
Price Targets
KOD
Kodiak Sciences Inc
45% Downside
HPHA
Heidelberg Pharma AG
370% Upside
CANTA
Cantargia AB
424% Upside
MRUS
Merus NV
76% Upside
301207
Hualan Biological Bacterin Inc
45% Upside
397030
AprilBio Co Ltd
44% Upside
BVXP
Bioventix PLC
52% Upside
BIOCON
Biocon Ltd
3% Upside

Revenue
Forecast

Revenue Estimate
InnoCare Pharma Ltd

For the last 1 year the compound annual growth rate for InnoCare Pharma Ltd's revenue is -40%. The projected CAGR for the next 4 years is 32%.

-40%
Past Growth
32%
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Operating Income
Forecast

Operating Income Estimate
InnoCare Pharma Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
InnoCare Pharma Ltd

N/A
Past Growth
N/A
Estimated Growth
N/A
Estimates Accuracy
N/A
Average

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is InnoCare Pharma Ltd's stock price target?
Price Target
16.22 CNY

According to Wall Street analysts, the average 1-year price target for InnoCare Pharma Ltd is 16.22 CNY with a low forecast of 16.06 CNY and a high forecast of 16.7 CNY.

What is InnoCare Pharma Ltd's Revenue forecast?
Projected CAGR
32%

For the last 1 year the compound annual growth rate for InnoCare Pharma Ltd's revenue is -40%. The projected CAGR for the next 4 years is 32%.

Back to Top